COMMUNIQUÉS West-GlobeNewswire

Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
18/08/2026
Event and Webcast to be held August 20th, 2026, 9:00 AM ET MILLBRAE, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated [...]
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment
18/08/2026
Follows recent European patent grant and coverage in multiple international markets as Silo continues to strengthen licensed IP portfolio for lead therapeutic program SARASOTA, FLA., Aug. 18, 2026 (GLOBE NEWSWIRE) -- [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
WALTHAM, Mass., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market
18/08/2026
Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations FullPAC (NASDAQ [...]
Immunocine Cancer Center Expands as Demand Grows for Personalized Dendritic Cell Therapy
18/08/2026
HOUSTON, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Responding to a growing number of patients seeking personalized cancer immunotherapy, Immunocine Cancer Center has opened a second treatment location in Cabo San Lucas, Mexico [...]
Psyence BioMed Welcomes U.S. Administration’s Latest Action to Accelerate Ibogaine Development
18/08/2026
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd [...]
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
18/08/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available NEWPORT BEACH, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Hoag announced today [...]
Two physicians at The Wall Center named to America's Best Plastic Surgeons 2026 — a first for any Shreveport practice
18/08/2026
SHREVEPORT, La., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The Wall Center for Plastic Surgery announced today that two of its surgeons have been named to Newsweek 's America's Best Plastic Surgeons 2026 list, ranked in [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 14, 2026 it granted stock options to purchase an aggregate of 27,565 shares of [...]
Ketogenic Foundation Announces 2026 Conference Exploring the Future of Metabolic Health and Chronic Disease Care
18/08/2026
Researchers, clinicians, healthcare leaders, and advocates will convene October 4–7 in Dallas to examine emerging science and its translation into chronic disease care DALLAS, Aug. 18, 2026 (GLOBE NEWSWIRE) -- The [...]
USAHS Celebrates 20,000 Degrees Amid Continued Growth and Program Expansion
18/08/2026
Achievements reflect continued momentum in preparing clinicians and expanding access to care ST. AUGUSTINE, Fla., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS), a leading [...]
Trethera Appoints World-Renowned ALS Researcher Dr. Merit Cudkowicz to Scientific Advisory Board
18/08/2026
LOS ANGELES, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation ("Trethera"), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer, autoimmune diseases, and neuroimmune disorders [...]
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t
18/08/2026
NeOnc Insider Open Market Buying may be the Signal Worth Watching DENVER, Aug. 18, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- NeOnc Technologies Holdings (NASDAQ: NTHI) has just added another potentially important [...]
Jabra Enhance introduces a new lineup of FDA-cleared self-fitting hearing aids, 3 new models with improved hearing technology and in-app self-tuning
18/08/2026
SHAKOPEE, Minn., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Jabra Enhance, a leader in virtual audiology and direct-to-consumer hearing care, launched its next-generation M Series with three new FDA-cleared self-fitting hearing [...]
Direct Meds Updates DirectMax Clinical Review and Licensed-Pharmacy Fulfillment Details (2026)
18/08/2026
Direct Meds has broadened the patient-facing information available for DirectMax, covering its online clinical-review process, the compounded status of the medication, its licensed-pharmacy fulfillment model, recurring- [...]
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
18/08/2026
Discussion Paper Supports FDA’s Innovation and Global Leadership Strategic Pillar; Public Docket Opens on Regulations.gov Silver Spring, Md., Aug. 18, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today [...]
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
18/08/2026
Acquisition expands Cellution Biologics’ human tissue-based portfolio and marks its entry into the U.S. reconstructive surgery market ROSWELL, Ga., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cellution Biologics Inc. (“Cellution [...]
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
18/08/2026
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026 Halle (Saale) / Munich, Germany, August 18, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon [...]
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
18/08/2026
Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization [...]

Pages